We have on a number of occasions spoken with colleagues. For example, we've made presentations along with the EMEA, and we've panelled together with the FDA, the WHO. We're all sitting in the same rooms with colleagues from Africa and other places that could potentially use the system. We make joint presentations. The same issue comes up for all of us--namely, that drugs are not moving under the various programs.
On April 16th, 2007. See this statement in context.